Created at	Source	Raw Value	Validated value
Dec. 17, 2021, 2 a.m.	usa	OPA GMT with V114;Opsonophagocytic activity (OPA) Geometric mean titer (GMT) with V110;Participants with solicited injection-site adverse events (AEs);Participants with solicited systemic AEs;Participants with vaccine-related serious AEs (SAEs);SARS-CoV-2-specific binding antibody (bAb) GMT	OPA GMT with V114;Opsonophagocytic activity (OPA) Geometric mean titer (GMT) with V110;Participants with solicited injection-site adverse events (AEs);Participants with solicited systemic AEs;Participants with vaccine-related serious AEs (SAEs);SARS-CoV-2-specific binding antibody (bAb) GMT